Svas Biosana Statistics

Total Valuation

Svas Biosana has a market cap or net worth of EUR 44.10 million. The enterprise value is 89.03 million.

Market Cap	44.10M
Enterprise Value	89.03M

Important Dates

The last earnings date was Friday, September 26, 2025.

Earnings Date	Sep 26, 2025
Ex-Dividend Date	Jun 9, 2025

Share Statistics

Svas Biosana has 5.31 million shares outstanding.

Current Share Class	5.31M
Shares Outstanding	5.31M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.45%
Owned by Institutions (%)	9.10%
Float	1.87M

Valuation Ratios

The trailing PE ratio is 6.54 and the forward PE ratio is 5.93.

PE Ratio	6.54
Forward PE	5.93
PS Ratio	0.33
PB Ratio	0.68
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.54, with an EV/FCF ratio of -20.54.

EV / Earnings	13.20
EV / Sales	0.66
EV / EBITDA	5.54
EV / EBIT	8.07
EV / FCF	-20.54

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 1.13.

Current Ratio	1.79
Quick Ratio	1.29
Debt / Equity	1.13
Debt / EBITDA	4.54
Debt / FCF	-16.84
Interest Coverage	2.57

Financial Efficiency

Return on equity (ROE) is 10.92% and return on invested capital (ROIC) is 5.30%.

Return on Equity (ROE)	10.92%
Return on Assets (ROA)	4.08%
Return on Invested Capital (ROIC)	5.30%
Return on Capital Employed (ROCE)	10.34%
Revenue Per Employee	412,570
Profits Per Employee	20,623
Employee Count	327
Asset Turnover	0.80
Inventory Turnover	2.88

Taxes

In the past 12 months, Svas Biosana has paid 2.37 million in taxes.

Income Tax	2.37M
Effective Tax Rate	26.02%

Stock Price Statistics

The stock price has increased by +4.40% in the last 52 weeks. The beta is 0.95, so Svas Biosana's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	+4.40%
50-Day Moving Average	8.15
200-Day Moving Average	7.74
Relative Strength Index (RSI)	56.26
Average Volume (20 Days)	1,759

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Svas Biosana had revenue of EUR 134.91 million and earned 6.74 million in profits.

Revenue	134.91M
Gross Profit	37.12M
Operating Income	11.03M
Pretax Income	9.12M
Net Income	6.74M
EBITDA	16.08M
EBIT	11.03M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 28.09 million in cash and 73.00 million in debt, giving a net cash position of -44.92 million or -8.45 per share.

Cash & Cash Equivalents	28.09M
Total Debt	73.00M
Net Cash	-44.92M
Net Cash Per Share	-8.45
Equity (Book Value)	64.64M
Book Value Per Share	n/a
Working Capital	58.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -552,693 and capital expenditures -3.78 million, giving a free cash flow of -4.33 million.

Operating Cash Flow	-552,693
Capital Expenditures	-3.78M
Free Cash Flow	-4.33M
FCF Per Share	-0.82

Full Cash Flow Statement

Margins

Gross margin is 27.52%, with operating and profit margins of 8.18% and 5.00%.

Gross Margin	27.52%
Operating Margin	8.18%
Pretax Margin	6.76%
Profit Margin	5.00%
EBITDA Margin	11.92%
EBIT Margin	8.18%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 3.01%.

Dividend Per Share	0.25
Dividend Yield	3.01%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	19.64%
Buyback Yield	n/a
Shareholder Yield	3.01%
Earnings Yield	15.29%
FCF Yield	-9.83%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3